Medicine that’s
RIGHT FOR OUR PATIENTS
Azurity specializes in providing safe, high-quality treatments for patients requiring customized formulations for their care.
Medicine that’s
RIGHT FOR OUR PATIENTS
Azurity specializes in providing safe, high quality treatments for patients requiring customized formulations for their care. Azurity focuses on the needs of patients, such as children and the elderly, requiring customized, user-friendly drug formulations.
Medicine that’s
RIGHT FOR OUR PATIENTS
Azurity specializes in providing safe, high quality treatments for patients requiring customized formulations for their care. Azurity focuses on the needs of patients, such as children and the elderly, requiring customized, user-friendly drug formulations.
Medicine That’s Easy to Give…
and to Take
Azurity’s products have benefited millions of patients whose needs are not served by other commercially available therapies.
Azurity currently offers a comprehensive product portfolio that serves multiple therapeutic areas, with more on the way!
FDA-APPROVED PRODUCTS
A growing portfolio of products designed to fulfill unmet needs of both pediatric and elderly patients.
Labels for representation purposes only
NON-FDA APPROVED FIRST® COMPOUNDING KITS
A family of prescription compounding kits designed as an alternative to conventional dosage forms.
Labels for representation purposes only
Pharmacist to Pharmacist
Challenged by the ever-changing compounding landscape? Don’t be. Click to learn How FIRST® Kits Help Pharmacists – professionals like you – facilitate their obligations under 503A and USP <795>.
Visit our resource center now to learn more
Compounding made convenient & consistent.
Pharmacist to Pharmacist
Challenged by the ever-changing compounding landscape? Don’t be.
Click to learn How FIRST® Kits Help Pharmacists – professionals like you – facilitate their obligations under 503A and USP <795>.
Visit our resource center now to learn more
Compounding made convenient & consistent.
News & Events
Azurity Pharmaceuticals Completes Acquisition of Arbor Pharmaceuticals
WOBURN, MA & ATLANTA, GA (September 20, 2021) – Azurity Pharmaceuticals, Inc. (“Azurity”) is pleased to announce the closing of its acquisition of Arbor Pharmaceuticals, Inc. (“Arbor”), as previously announced on August 24, 2021. The acquisition creates a leading company offering innovative, high-value products to meet the unique needs of patients...
Azurity Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of One Lot of Firvanq® (vancomycin hydrochloride for oral solution), Vancomycin 50 mg/mL Kit, Due to a Mix-Up of the Diluent Included in the Kit
FOR IMMEDIATE RELEASE – September 7, 2021 – Wilmington, MA, Azurity Pharmaceuticals, Inc. (“Azurity”) is voluntarily recalling one lot of Firvanq® (vancomycin hydrochloride for oral solution), Vancomycin 50 mg/mL Kit (“Firvanq®”) to the consumer level, as some products in the affected lot have been found to incorrectly contain a First Omeprazole (FIRST-PPI) diluent instead of the Firvanq diluent bottle.